Strides Shasun announced that its wholly owned subsidiary Strides Pharma Global Pte. Limited has received final approval for Cinacalcet
Hydrochloride Tablets, 30 mg (base), 60 mg (base), and 90 mg (base) from the United States Food & Drug Administration (US FDA). Cinacalcet Hydrochloride Tablets is a generic version of Sensipar Tablets of Amgen Inc.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
